Departments of Urology and Medical Social Sciences (DEV), Northwestern University Feinberg School of Medicine, Chicago, Illinois.
Departments of Urology and Medical Social Sciences (DEV), Northwestern University Feinberg School of Medicine, Chicago, Illinois.
J Urol. 2018 Nov;200(5):1048-1055. doi: 10.1016/j.juro.2018.05.093. Epub 2018 May 29.
Shared decision making is recommended in regard to prostate cancer screening. Decision aids may facilitate this process but the impact of decision aids on screening preferences is poorly understood.
In an online survey we randomized a national sample of adults to the online decision aids of 1 of 6 professional societies. We compared survey responses before and after decision aid exposure. The primary outcome was the change in participant likelihood of undergoing or recommending prostate cancer screening on a scale of 1-unlikely to 100-extremely likely. Secondary outcomes included change in participant comfort with prostate cancer screening based on the average of 6, 5-point Likert-scale questions.
Median age was 53 years in the 1,336 participants and 50% were men. The randomized groups did not differ significantly by race, age, gender, income, marital status or education level. The likelihood of undergoing or recommending prostate cancer screening decreased from 83 to 78 following decision aid exposure (p <0.001). Reviewing the decision aid from the Centers for Disease Control or the American Academy of Family Physicians did not alter the likelihood (each p >0.2). However, the decision aid from the United States Preventive Services Task Force was associated with the largest decrease in screening preference (-16.0, p <0.001). Participants reported increased comfort (from 3.5 to 4.1 of 5) with the decision making process of prostate cancer screening following exposure to a decision aid (p <0.001).
Exposure to a decision aid decreased the participant likelihood of undergoing or recommending prostate cancer screening and increased comfort with the screening process.
建议在前列腺癌筛查方面进行共同决策。决策辅助工具可以促进这一过程,但决策辅助工具对筛查偏好的影响知之甚少。
在一项在线调查中,我们将全国成年人样本随机分配到 6 个专业协会的在线决策辅助工具中。我们比较了决策辅助工具暴露前后的调查结果。主要结果是参与者进行或推荐前列腺癌筛查的可能性变化,范围为 1-极不可能,100-极有可能。次要结果包括根据 6 个 5 分李克特量表问题的平均值,参与者对前列腺癌筛查的舒适度变化。
1336 名参与者的中位年龄为 53 岁,其中 50%为男性。随机分组在种族、年龄、性别、收入、婚姻状况或教育水平方面没有显著差异。在决策辅助工具暴露后,进行或推荐前列腺癌筛查的可能性从 83 降至 78(p<0.001)。查看疾病控制中心或美国家庭医生学会的决策辅助工具并没有改变这种可能性(p>0.2)。然而,美国预防服务工作组的决策辅助工具与筛查偏好的最大降幅(-16.0,p<0.001)相关。参与者报告说,在接触决策辅助工具后,他们对前列腺癌筛查决策过程的舒适度(从 3.5 提高到 4.1)增加(p<0.001)。
接触决策辅助工具降低了参与者进行或推荐前列腺癌筛查的可能性,并增加了对筛查过程的舒适度。